Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ocera Therapeutics OCRX

Healthcare Biotechnology
"Ocera Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease."

Recent & Breaking News (NDAQ:OCRX)

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Ocera Therapeutics, Inc.

GlobeNewswire December 7, 2017

Lifshitz & Miller LLP Announces Investigation of Manitex International, Inc., Novan, Inc., Ocera Therapeutics, Inc., Planet Payment, Inc., RE/MAX Holdings, Inc., Super Micro Computer, Inc. and World Acceptance Corporation

PR Newswire November 16, 2017

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Ocera Therapeutics, Inc. - OCRX

PR Newswire November 2, 2017

OCERA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

Business Wire November 2, 2017

Mid-Afternoon Market Update: Ocera Therapeutics Surges Following Acquisition News; IMPINJ Shares Plunge

Benzinga.com  November 2, 2017

Mid-Day Market Update: AAC Holdings Climbs On Earnings Beat; KEMET Shares Slide

Benzinga.com  November 2, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Clifton Bancorp Inc. to Kearny Financial Corp. is Fair to Shareholders – CSBK

Business Wire November 2, 2017

Mallinckrodt To Acquire Ocera Therapeutics And OCR-002, Its Proprietary Therapy In Development For Treatment Of Hepatic Encephalopathy

PR Newswire November 2, 2017

Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®

GlobeNewswire October 20, 2017

Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017

GlobeNewswire August 23, 2017

Ocera Therapeutics Reports Second Quarter 2017 Financial Results

GlobeNewswire August 1, 2017

Biotech Stock Performance Review -- NewLink Genetics, Ocera Therapeutics, Ocular Therapeutix, and Omeros

PR Newswire July 11, 2017

Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis

GlobeNewswire June 1, 2017

Ocera Therapeutics to Host KOL Conference Call on Hepatic Encephalopathy and Other Complications of Liver Disease on Friday, June 2

GlobeNewswire May 26, 2017

Biotech Stocks Under Scanner -- Bioverativ, Zosano Pharma, MannKind, and Ocera Therapeutics

PR Newswire May 10, 2017

Ocera Therapeutics Reports First Quarter 2017 Financial Results and Provides Clinical Update

GlobeNewswire May 9, 2017

Investor Network: Ocera Therapeutics, Inc. to Host Earnings Call

Accesswire May 9, 2017

Ocera Therapeutics to Report First Quarter 2017 Financial Results and Provide Clinical Update on May 9, 2017

GlobeNewswire May 3, 2017

10 Biggest Mid-Day Gainers For Thursday

Benzinga.com  April 13, 2017

Ocera Therapeutics Announces Presentation of Data Showing OCR-002 Prevented Progression of Fibrosis in Preclinical Model of Non-alcoholic Fatty Liver Disease (NAFLD)

GlobeNewswire April 12, 2017